CSPC Pharmaceutical Group Limited
CSPCY | OTC
$4.07
+$0.13 (+3.30%)
Nov 2, 2026, 11:13 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | 10.72 | 24.79 | 23.33 | 12.92 | 12.44 | 14.52 | 13.10 | 15.77 | 16.57 | 18.02 | 22.94 |
PEG Ratio | 0.03 | -0.55 | 0.23 | -0.22 | 1.49 | -1.89 | n/a | n/a | 0.70 | -0.94 | 1.76 |
PS Ratio | 2.58 | 3.80 | 3.39 | 1.89 | 2.34 | 2.70 | 2.54 | 3.14 | 3.10 | 3.66 | 5.23 |
PB Ratio | 2.11 | 2.93 | 2.65 | 1.72 | 2.11 | 2.60 | 2.55 | 3.29 | 3.31 | 3.90 | 5.48 |
P/FCF Ratio | 6.51 | 23.92 | 23.03 | 21.95 | 25.64 | 33.95 | 37.45 | 17.78 | 19.79 | 32.55 | 22.58 |
P/OCF Ratio | 5.76 | 16.17 | 13.50 | 11.83 | 17.10 | 19.60 | 17.70 | 12.73 | 14.03 | 20.83 | 18.78 |
OCF/S Ratio | 60.10 | 22.07 | 24.91 | 25.29 | 8.68 | 19.17 | 8.97 | 20.32 | 28.70 | 14.43 | 20.71 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | 0 | 0.01 |
Quick Ratio | 1.93 | 1.88 | 1.95 | 1.95 | 2.20 | 2.29 | 2.40 | 2.39 | 2.39 | 2.47 | 2.50 |
Current Ratio | 2.14 | 2.19 | 2.24 | 2.27 | 2.54 | 2.63 | 2.70 | 2.67 | 2.70 | 2.81 | 2.76 |
Asset Turnover | 0.33 | 0.27 | 0.28 | 0.29 | 0.34 | 0.33 | 0.38 | 0.36 | 0.41 | 0.40 | 0.42 |
Interest Coverage | 551.62 | 82.75 | 118.65 | 76.55 | n/a | 380.94 | 579.06 | 80.20 | 520.21 | 887.82 | 541.25 |
Return on Equity | 15.98% | 3.95% | 7.52% | 4.13% | 8.74% | 8.59% | 9.74% | 4.80% | 10.90% | 9.68% | 12.48% |
Return on Assets | 10.73% | 2.81% | 5.43% | 3% | 6.36% | 6.16% | 7.10% | 3.42% | 7.87% | 7.24% | 9.31% |
Return on Invested Capital | 14.85% | 2.87% | 5.74% | 3.48% | 7.91% | 7.61% | 8.68% | 3.60% | 9.42% | 9.10% | 10.10% |
Dividend Yield | 2.15% | 2.53% | 1.30% | 3.12% | 2.08% | 1.84% | 1.55% | 1.01% | 1.13% | 0.78% | 0.67% |
Payout Ratio | 28.46% | 187.17% | 45.75% | 130.28% | 50.29% | 55.71% | 40.57% | 69.02% | 34.36% | 31.53% | 29.29% |
FCF Payout Ratio | n/a | 123.03% | n/a | 104.12% | 232.81% | 80.89% | 393.72% | 59.24% | 28.43% | 86.89% | 40.86% |
Gross Profit Margin | 76.15% | 65.57% | 65.62% | 67.93% | 71.57% | 71.17% | 69.88% | 71.23% | 72.64% | 75.55% | 76.14% |
Net Profit Margin | 32.77% | 10.48% | 19.20% | 10.28% | 18.55% | 18.91% | 18.45% | 9.46% | 19% | 18.10% | 22.16% |
Pretax Profit Margin | 40.49% | 13.28% | 23.49% | 13.97% | 23.34% | 24.12% | 22.89% | 11.79% | 23.83% | 22.67% | 26.50% |
Operating Profit Margin | 39.51% | 11.01% | 19.35% | 13.05% | 22.67% | 22.85% | 21.69% | 9.57% | 22.20% | 22.31% | 22.51% |
FCF Margin | 55.71% | 15.94% | 15.85% | 13.57% | 4.73% | 13.94% | 2.61% | 11.42% | 23.49% | 6.58% | 15.92% |
EBITDA Margin | 43.07% | 16.66% | 28.94% | 19.99% | 27.66% | 28.25% | 26.37% | 29.09% | 26.96% | 25.64% | 29.63% |
Add to Watchlist
Select watchlists to add or remove CSPCY